Quantcast

Latest Angiotech Pharmaceuticals Inc. Stories

2009-04-24 12:42:00

VANCOUVER, April 24 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") (NASDAQ: ANPI, TSX: ANP) today announced that its 2009 annual general meeting of shareholders will take place on June 4, 2009 at 10:00 a.m. Pacific time, at the Westin Grand Vancouver, 403 Robson Street, Vancouver, BC V6B 6L9. The record date for shareholders entitled to receive notice of and vote at the meeting will be April 27, 2009, and Angiotech expects to mail the meeting materials to shareholders...

2009-03-31 07:30:00

VANCOUVER, March 31 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced it has completed an Amended and Restated Distribution and License Agreement with its partner Baxter International Inc. (Baxter). As consideration for the Amended and Restated Distribution and License Agreement, Angiotech will receive $25 million. Angiotech and Baxter initially entered into a Distribution and License Agreement in 2003 relating to certain intellectual property...

2009-03-09 19:30:00

VANCOUVER, March 9 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced positive clinical study results for its Bio-Seal(TM) Lung Biopsy Tract Plug System at the Society of Interventional Radiologists Annual Scientific Meeting in San Diego, CA. The trial assessed the safety and efficacy of Bio-Seal in patients undergoing lung biopsy procedures and demonstrated a statistically significant clinical benefit in the group receiving BioSeal. "We are...

2009-03-05 07:30:00

VANCOUVER, March 5 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced its financial results for the fourth quarter and year ended December 31, 2008. "During 2008 we achieved solid sales results in our Medical Products Business and were able to sustain progress on our most important new technology initiatives despite a challenging year for TAXUS," said Dr. William Hunter, President and CEO of Angiotech. "Not only did we increase Medical Products...

2009-03-02 07:30:00

VANCOUVER, March 2 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced it has obtained a new Senior Secured Term Loan and Revolving Credit Facility. Wells Fargo Foothill, LLC is the sole arranger, administrative agent and lender for both the Term Loan and Revolving Credit Facility. The financing includes a delayed draw secured term loan facility of up to $10 million, and a secured revolving credit facility with a borrowing base derived from the...

2009-02-26 07:30:00

VANCOUVER, Feb. 26 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI; TSX: ANP), a global specialty pharmaceutical and medical device company, today announced that it has received 510(k) clearance to begin marketing the Quill(TM) SRS Polydioxanone (PDO), MONODERM(TM) and Nylon product lines in Canada. "With the approval of the PDO, MONODERM(TM) and Nylon product lines in Canada, we can further extend the global reach of this next-generation suture product beyond the U.S....

2009-02-24 07:30:00

VANCOUVER, Feb. 24 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, today announced a time change of its fourth quarter and year end conference call. The call will take place at 10:00 AM ET (7:00 AM PT) on Thursday, March 5, 2009. Dial information for the earnings call on March 5, 2009 has not changed and is as follows: North America (toll-free): (800) 291-9234 International:...

2009-02-17 07:30:00

FOURTH QUARTER AND YEAR END 2008 FINANCIAL RESULTS VANCOUVER, Feb. 17 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, will host a conference call discussing its financial results for the fourth quarter and year ended December 31, 2008 on Thursday, March 5, 2009 at 11:00 AM ET (8:00 AM Pacific). Dial information for the earnings call on March 5, 2009 is as follows: North America...

2008-09-25 15:00:56

VANCOUVER, Sept. 25 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. ("Angiotech") , a global specialty pharmaceutical and medical device company, today announced that its 2008 annual and special general meeting of shareholders will take place on October 30, 2008 at 8:30am Pacific time, at the Sheraton Vancouver Wall Centre, 1088 Burrard Street, Vancouver, BC V6Z 2R9. The record date for shareholders entitled to receive notice of and vote at the meeting will be September 30, 2008,...

2008-09-22 09:00:59

VANCOUVER, Sept. 22 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. ("Angiotech") , a global specialty pharmaceutical and medical device company, today announced that it is pursuing various initiatives to reduce operating costs and to further focus its business efforts, pending continued exploration of alternatives to the Company's balance sheet and current capital structure. Options to be explored, among others, include determining whether the Company will be able to consummate...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related